Periodic Reporting for period 1 - BOB (Business Opportunities in Biotech: Innovation Associate to leverage cell-free synthetic biology)

c-LEcta is about to expand its outstanding cell-free synthetic biology (CFSB) platform which enables the ecofriendly and cost-competitive enzymatic production of naturally occurring high value ingredients that are hardly accessible due to e.g. limited natural resources and/or...